These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2638825)

  • 1. [Radioprotective effect of ascorbic acid on oral structures in patients with cancer of the head and neck].
    Garcia-Alejo Hernández R; Martín de Miguel MJ; Seoane Lestón JM; Romero Méndez MA; Esparza Gómez GC
    Av Odontoestomatol; 1989 Sep; 5(7):469-72. PubMed ID: 2638825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral management of the patient with cancer in the head and neck region.
    Barker BF; Barker GJ
    J Calif Dent Assoc; 2001 Aug; 29(8):619-23. PubMed ID: 11577673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental implications and management of head and neck radiotherapy patients.
    Andrews N
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():90-7. PubMed ID: 11709989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental management of patients undergoing radiation therapy for cancer of the head and neck.
    Miller EC; Vergo TJ; Feldman MI
    Compend Contin Educ Dent (Lawrenceville); 1981; 2(6):350-6. PubMed ID: 6950869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral aspects of radiotherapy and/or chemotherapy in the head and neck area].
    Leenstra TS; Panders AK; Vermey A; Spijkervet FK; Roodenburg JL; Reintsema H
    Ned Tijdschr Tandheelkd; 1990 Jan; 97(1):17-22. PubMed ID: 2366921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
    Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
    Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioprotective effects on head and neck tumors of amifostine--a broad-spectrum cytoprotection].
    Huang R; Yu H; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Dec; 19(4):708-11. PubMed ID: 12561384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.
    Veerasarn V; Phromratanapongse P; Suntornpong N; Lorvidhaya V; Sukthomya V; Chitapanarux I; Tesavibul C; Swangsilpa T; Khorprasert C; Shotelersuk K; Kongthanarat Y; Panichevaluk A; Chiewvit S; Pusuwan P; Aekmahachai M; Ratchadara S; Sirilipoche S; Saengsuda Y
    J Med Assoc Thai; 2006 Dec; 89(12):2056-67. PubMed ID: 17214057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of oral health in patients irradiated for head and neck cancer: a review.
    Shenoy VK; Shenoy KK; Rodrigues S; Shetty P
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):117-20. PubMed ID: 18604001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of post radiation therapy patients.
    Levin AC; Ferris GM
    Fla Dent J; 1980 Nov; 51(2):41-4. PubMed ID: 6939599
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
    Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial.
    Ferreira PR; Fleck JF; Diehl A; Barletta D; Braga-Filho A; Barletta A; Ilha L
    Head Neck; 2004 Apr; 26(4):313-21. PubMed ID: 15054734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.
    Bourhis J; Rosine D
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):61-2. PubMed ID: 12577247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on oral complications of head and neck cancer radiotherapy.
    Makkonen T
    Proc Finn Dent Soc; 1988; 84 Suppl 4-5():1-111. PubMed ID: 3405992
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
    Anné PR
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and emerging uses of cytoprotection in head and neck cancer.
    Rosenthal DI
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):129-30. PubMed ID: 16490868
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral care of cancer patients undergoing head and neck irradiation.
    Bennett J
    Dent Hyg (Chic); 1979 May; 53(5):209-12. PubMed ID: 296026
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of saliva in oral health: strategies for prevention and management of xerostomia.
    Brosky ME
    J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the dentist in the reduction of oral complications caused by radiotherapy in head and neck cancer].
    Nagy K
    Fogorv Sz; 2005 Apr; 98(2):59-63. PubMed ID: 15957502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.